CoChat

Cerebral microbleeds, retinopathy, and dementia: The AGES-Reykjavik Study

Open access
Qiu, C., Cotch, M.F., Sigurdsson, S., Jonsson, P.V., Jonsdottir, M.K., Sveinbjrnsdottir, S., Eiriksdottir, G., Klein, R., Harris, T.B., van Buchem, M.A., Gudnason, V., Launer, L.J. · 2010 · Neurology

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To determine whether microvascular damage, indicated by cerebral microbleeds (CMBs) and retinal microvascular signs, is associated with cognitive function and dementia in older persons. METHODS: This is a cross-sectional study of 3,906 participants (mean age 76 years; 58% women) in the AGES-Reykjavik Study (2002-2006). We assessed CMBs on MRI and retinal microvascular signs on digital retinal images. Composite Z scores of memory, processing speed, and executive function were derived from a battery of neurocognitive tests. Dementia and subtypes were diagnosed following international criteria. Regression models were used to relate cognitive Z scores and dementia to CMBs and retinal microvascular signs, adjusting for demographics, cardiovascular factors, and brain ischemic lesions. RESULTS: People with multiple (≥ 2) CMBs had lower Z scores on tests of processing speed (β-coefficient -0.16; 95% confidence interval -0.26 to -0.05) and executive function (-0.14; -0.24 to -0.04); results were strongest for having multiple CMBs located in the deep hemispheric or infratentorial areas. The odds ratio of vascular dementia was 2.32 (95% confidence interval 1.02 to 5.25) for multiple CMBs and 1.95 (1.04 to 3.62) for retinopathy. Having both CMBs and retinopathy, compared to having neither, was significantly associated with markedly slower processing speed (-0.25; -0.37 to -0.12), poorer executive function (-0.19; -0.31 to -0.07), and an increased odds ratio of vascular dementia (3.10; 1.11 to 8.62). CONCLUSION: Having multiple CMBs or concomitant CMBs and retinopathy is associated with a profile of vascular cognitive impairment. These findings suggest that microvascular damage, as indicated by CMBs and retinopathy lesions, has functional consequences in older men and women living in the community.

Overview

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e3182020349

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Cited by

See all 237

Metadata

Authors
Qiu, C., Cotch, M. F., Sigurdsson, S., Jonsson, P. V., Jonsdottir, M. K., Sveinbjrnsdottir, S., Eiriksdottir, G., Klein, R., Harris, T. B., van Buchem, M. A., Gudnason, V., & Launer, L. J.
Affiliations
  • Karolinska Institutet (SE)
  • From the Laboratory of Epidemiology, Demography and Biometry (C.Q., T.B.H., L.J.L.), National Institute on Aging, Bethesda, MD; Aging Research Center (C.Q.), Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Division of Epidemiology and Clinical Applications (M.F.C.), National Eye Institute, Bethesda, MD; Icelandic Heart Association (S.S., P.V.J., M.K.J., G.E., V.G.), Kopavogur; Landspitali University Hospital (P.V.J., M.K.J., S.S.), Reykjavik; Faculty...
Venue
Neurology
Published
2010-12-14
Volume
75
Issue
24
Pages
2221-2228
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2087725934
Cited by
237
References
43
Citations by year
2026: 5 · 2025: 7 · 2024: 20 · 2023: 15 · 2022: 14 · 2021: 15 · 2020: 18 · 2019: 10 · 2018: 14 · 2017: 12 · 2016: 25 · 2015: 20 · 2014: 26 · 2013: 15 · 2012: 16
FWCI
7.87
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Hirsla (Landspítali University Hospital) (submittedVersion)
Funders
  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • Hjartavernd (N01-AG-1-2100)
  • National Institutes of Health (n01ag12100-57-0-2, N01-AG-1-2100, Z99 EY999999)
  • Genentech
  • U.S. Public Health Service (ZIAEY000401)
  • Allergan
  • National Institute on Aging (N01-AG12100)
  • National Eye Institute (ZIAEY000401, EY-016379, Z01EY000401, R01EY016379)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
  • Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
Keywords
cerebral microbleeds, retinopathy, dementia, vascular dementia, microvascular damage, cognitive impairment, processing speed, executive function, memory, older adults, deep cerebral microbleeds
MeSH terms
Aged, Aged, 80 and over, Aging, Brain, Cerebral Hemorrhage, Cerebrovascular Circulation, Cognition, Cross-Sectional Studies, Dementia, Female, Humans, Iceland, Magnetic Resonance Imaging, Male, Microcirculation, Neuropsychological Tests, Retinal Vessels, Risk Factors, Confidence Intervals, Executive Function

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebral microbleeds, retinopathy, and dementia: The AGES-Reykjavik Study. https://app.cochat.ai/papers/10.1212/wnl.0b013e3182020349
The paper
Qiu, C., Cotch, M. F., Sigurdsson, S., Jonsson, P. V., Jonsdottir, M. K., Sveinbjrnsdottir, S., Eiriksdottir, G., Klein, R., Harris, T. B., van Buchem, M. A., Gudnason, V., & Launer, L. J. (2010). Cerebral microbleeds, retinopathy, and dementia: The AGES-Reykjavik Study. Neurology. https://doi.org/10.1212/wnl.0b013e3182020349

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.